Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2021-08-11 00:00:00 ET · period of report 2021-08-09 · accession 0001213900-21-041712 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-11 | 2021-08-09 | ORMP | RAKIN KEVIN | Dir | F - Tax | $21.09 | -26.1K | 19.1K | -58% | -$550.3K |
| DM | 2021-08-11 | 2021-08-09 | ORMP | RAKIN KEVIN | Dir | M - OptEx | $6.95 | +79.1K | 34.2K | New | +$550.3K |
| DM | 2021-08-11 | 2021-08-09 | ORMP | RAKIN KEVIN | Dir | M - OptEx | $0.00 | -79.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-09 | F | D | 1,517 | $21.09 | 24,224 | D | — | — | (F2) Represents a cashless exercise of outstanding stock options to purchase 6,666 shares of common stock. The reporting person received 5,149 shares of common stock and surrendered 1,517 shares of common stock underlying the stock option in payment of the exercise price. |
| 2 | Common | Common Stock | 2021-08-09 | F | D | 1,977 | $21.09 | 32,247 | D | — | — | (F3) Represents a cashless exercise of outstanding stock options to purchase 10,000 shares of common stock. The reporting person received 8,023 shares of common stock and surrendered 1,977 shares of common stock underlying the stock option in payment of the exercise price. |
| 3 | Common | Common Stock | 2021-08-09 | M | A | 56,773 | $7.77 | 89,020 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-09 | F | D | 20,916 | $21.09 | 68,104 | D | — | — | (F4) Represents a cashless exercise of outstanding stock options to purchase 56,773 shares of common stock. The reporting person received 35,857 shares of common stock and surrendered 20,916 shares of common stock underlying the stock option in payment of the exercise price. |
| 5 | Common | Common Stock | 2021-08-09 | M | A | 6,666 | $4.80 | 25,741 | D | — | — | |
| 6 | Common | Common Stock | 2021-08-09 | F | D | 1,683 | $21.09 | 19,075 | D | — | — | (F1) Represents a cashless exercise of outstanding stock options to purchase 5,697 shares of common stock. The reporting person received 4,014 shares of common stock and surrendered 1,683 shares of common stock underlying the stock option in payment of the exercise price. |
| 7 | Common | Common Stock | 2021-08-09 | M | A | 5,697 | $6.23 | 20,758 | D | — | — | |
| 8 | Common | Common Stock | 2021-08-09 | M | A | 10,000 | $4.17 | 34,224 | D | — | — | |
| 9 | Derivative | Stock Option (right to buy) | 2021-08-09 | M | D | 10,000 | $0.00 | 0 | D | $4.17 · 2019-12-31 to 2029-09-11 | 10,000 Common Stock | |
| 10 | Derivative | Stock Option (right to buy) | 2021-08-09 | M | D | 5,697 | $0.00 | 0 | D | $6.23 · 2017-02-09 to 2027-02-09 | 5,697 Common Stock | |
| 11 | Derivative | Stock Option (right to buy) | 2021-08-09 | M | D | 56,773 | $0.00 | 0 | D | $7.77 · — to 2027-06-30 | 56,773 Common Stock | (F5) The options vested as follows: 15,591 vested on December 31, 2017, 2018 and 2019 and additional 10,000 vested on December 31, 2020. |
| 12 | Derivative | Stock Option (right to buy) | 2021-08-09 | M | D | 6,666 | $0.00 | 0 | D | $4.80 · 2020-12-31 to 2030-01-08 | 6,666 Common Stock |